Richelle Allen, PH.D. Psychologist - Clinical Medicare: May Accept Medicare Assignments Practice Location: 113 First Street, Connelly, NY 12417 Phone: 617-610-7017 |
News Archive
Researchers from VIB, UGent, the Geisel School of Medicine at Dartmouth and several collaborators developed a new antiviral strategy to fight human respiratory syncytial virus (RSV), a leading cause of lower respiratory tract infections in children.
Researchers from The Miriam Hospital have found that adding evidence-based weight loss strategies to a statewide wellness campaign improves weight loss outcomes among participants. The study and its findings are published online in advance of print in the American Journal of Public Health.
Researchers at the University of Pittsburgh School of Medicine have discovered a blood biomarker that predicts kidney transplant rejection with a lead time of about eight months, which could give doctors an opportunity to intervene and prevent permanent damage.
ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510(k) clearance of CarriGenĀ® Porous Bone Substitute Material. CarriGen is available for immediate sale through ETEX's independent sales force. CarriGen builds upon the clinically proven benefit of ETEX nanocrystalline calcium phosphate technology by adding the advantage of increased porosity and pore size. CarriGen is the first highly porous bone graft substitute that sets hard upon implantation for a complete defect fill.
"Despite calls from national and international organizations to integrate HIV and nutritional programs, data are lacking on how such programs can be effectively implemented in resource-poor settings, on the optimum content and duration of nutritional support, and on ideal target recipients," write the authors of a Clinical Infectious Diseases review that examines the relationship between HIV, nutritional deficiencies and food insecurity.
› Verified 4 days ago